Responding to COVID-19: A Science-Based Approach

Brought to you by the American Public Health Association and the National Academy of Medicine, this webinar series is exploring the state of the science surrounding the current outbreak of COVID-19 in the United States and globally, with a focus on the emerging evidence on how to best mitigate its impact. Hear from trusted experts in such fields as public health, infectious disease, risk communication, and crisis standards of care.

Webinar #13: Returning to K-12 Education — Using Science to Keep Children, Teachers and Staff Safe

Wendy Armstrong Caitlin Rivers Donna Mazyck Dorte Lange

The 13th webinar in the series covered: takeaways from recent data and expert opinion on opening K-12; lessons from K-12 reopening experiences in Europe; incorporation of pandemic health practices in schools; and plans for the Spring 2021 semester.

Our expert panel:

  • Wendy Armstrong, MD, Emory University (Moderator)
  • Caitlin Rivers, PhD, Johns Hopkins University Center for Health Security
  • Donna Mazyck, MS, RN, NASN, CAE, FNASN, National Association of School Nurses
  • Dorte Lange, Danish Union of Teachers

Webinar #12: Managing Ongoing Surges — Lessons from the Front Lines

The 12th COVID-19 Conversations webinar discussed best practices and lessons learned from the early months of COVID-19 that can be applied to states and localities now combatting surges, from both a health system and public health perspective.

Webinar #11: Reopening Colleges and Universities During COVID-19 — Keeping Students and Communities Healthy

The 11th COVID-19 Conversations webinar covered the variety of considerations being weighed before reopening colleges and universities in fall 2020, including the role of testing and contact tracing, responding to outbreaks, if sports can safely resume, and other strategies to prevent the spread of COVID-19 while allowing education to continue.

Webinar #10: Learning to Treat COVID-19 — Clinical Trials and Developing Therapeutics During a Pandemic 

The tenth COVID-19 Conversations webinar discussed how scientists are learning to treat COVID-19, including presentations on: how scientists have adapted clinical trials to respond to the restrictions and requirements of a pandemic response; best practices in clinical care for those with COVID-19 right now; and promising therapeutics and preventive drugs currently enrolled in clinical trials globally.

Webinar #9: The Road to Immunity During COVID-19 — Developing and Distributing a Vaccine

The ninth COVID-19 Conversations webinar covered the basics of vaccine development, how developing a vaccine for COVID-19 differs from "traditional" vaccine development, and what actions can be taken now and in the coming months to ensure our supply chain is ready to manufacture millions of doses of a vaccine.

Webinar #8: Summer of COVID-19 — Mitigating Direct and Indirect Impacts in the Coming Months

As we look forward to the summer months, what can we expect to see as states and communities loosen restrictions? The webinar explored how the normal course of events, including warming weather, tornadoes and hurricanes, months of stay at-home orders and loosening of restrictions, combine to impact health and well-being.

Webinar #7: Toward the 'New Normal' — Protecting Public Health as America Reopens      

The seventh COVID-19 Conversations webinar explored how public health, economic, and workforce priorities can be balanced to ensure a safe reopening of the country; how models can inform reopening and what data is still needed; how a nationwide testing strategy can support reopening strategies; and how to ensure the public has reliable, actionable, and understandable data to guide their personal decision-making.

Webinar #6: COVID-19 and Health Equity — Exploring Disparities and Long-Term Health Impacts   

The sixth COVID-19 Conversations webinar explored the disproportionate impact COVID-19 is having on minority communities, what we can do now to combat these disturbing health inequities, and what we can learn from past pandemics about how to provide equitable care to all. 

Webinar #5: COVID-19 Testing: Possibilities, Challenges, and Ensuring Equity   

This webinar gave an update on testing for COVID-19, what data different tests will provide, how we can use that data to inform plans to ease physical distancing, and the equity issues we must all consider regarding what populations can access testing and how we can ensure equal access for all. 

Webinar #4: Crisis Standards of Care During COVID-19 

The fourth COVID-19 Conversations webinar focused on enacting crisis standards of care during a pandemic, practical considerations for public health departments and hospital systems, and ethical considerations.    

Webinar #3: Emerging Evidence on COVID-19 Spread and Treatment

The third COVID-19 Conversations webinar examined early data on disease spread, potential treatment options, and some of the ethical implications that are even further complicated in the midst of a pandemic.    

Webinar #2: The Science of Social Distancing, Part 2

The second COVID-19 Conversations webinar: discussed benefit-risk analysis of social/physical distancing strategies, including for vulnerable populations; examined strategies for mitigating mental health impacts; and explored what science is available to guide eventual relaxation of measures. 

Webinar #1: The Science of Social Distancing, Part 1

In our first COVID-19 Conversations webinar, our lineup of public health, medical and emergency experts shared the science on social distancing as well as strategies to support it. And we explored how findings from past pandemics — as well as the current one — can shape responses today. 

More about the webinar series

The webinar series draws from and complements existing advisory activities underway at APHA and the National Academies, including the Standing Committee on Emerging Infectious Diseases and 21st Century Health Threats, which was convened for the purpose of advising the White House and federal agencies on the U.S. response to COVID-19.

The series rapidly and regularly provides trustworthy scientific analysis of the latest COVID-19 developments for the benefit of policymakers, public health and health care officials, and the general public. The series is exploring the scientific basis for guidance issued by government, health and public health organizations, and industry, as well as answer questions that are top of mind for its audiences.

Questions? Contact us.

Stay in the know


Questions? Need Help?